International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 2 , Pages 311-312 , 1 October 2008

Elective Nodal Irradiation (ENI) Doesn't Appear to Provide a Clear Benefit for Patients With Unresectable Non–Small-Cell Lung Cancer (NSCLC)

  • Steven E. Schild, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: Steven E. Schild, M.D., Department of Radiation Oncology, Mayo Clinic Arizona, 13400 E. Shea Blvd., Scottsdale, AZ 85259. Tel: (480) 301-8000; Fax: (480) 301-7687

Received 7 April 2008 ,Accepted 6 June 2008.

References 

  1. Belderbos JS, Heemsbergen WD, De Jaeger K, et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:126–134
  2. Rosenzweig KE, Sim SE, Mychalczak B, et al. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2001;50:681–685
  3. Hayman JA, Martel MK, Ten Haken RK, et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial. J Clin Oncol. 2001;19:127–136
  4. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer. 1994;10(Suppl. 1):S239–S244
  5. Curran WJ, Scott CB, Langer CJ, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410 [abstract #2499]. 2003 annual meeting of ASCO. Proc Am Soc Clin Oncol. 2003;22:621
  6. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med. 1990;323:940–945
  7. Schild SE, Stella PJ, Geyer SM, et al. Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002;54:370–378
  8. Fletcher GH, Shukovsky LJ. The interplay of radiocurability and tolerance in the irradiation of human cancers. J Radiol Electrol Med Nucl. 1975;56:383–400
  9. Mehta M, Scrimger R, Mackie R, et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2001;49:23–33
  10. Schild SE, McGinnis WL, Graham D, et al. Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;65:1106–1111
  11. Bradley J, Graham M, Swann S, et al. Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC. 2005 annual meeting of ASCO. [abstract #7063] Proc Am Soc Clin Oncol. 2005;23:636s
  12. Yuan S, Sun X, Li M, et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol. 2007;30:239–244

 Conflict of Interest: None.

PII: S0360-3016(08)02468-1

doi: 10.1016/j.ijrobp.2008.06.1485

International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 2 , Pages 311-312 , 1 October 2008

Article Tools